Last reviewed · How we verify
Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical
The purpose of this study is to determine whether Endostar pumping into vein with Thalidomide are more effective in the treatment of Advanced Colorectal Cancer (ACRC).
Details
| Lead sponsor | The First People's Hospital of Hefei |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 148 |
| Start date | 2016-01 |
| Completion | 2018-12 |
Conditions
- Colorectal Neoplasms
Interventions
- Two Anti-angiogenesis Drugs（Endostar and Thalidomide）
- Pure chemotherapy（Xelox）
Primary outcomes
- PFS — 2 Years
Adoption of internationally accepted evaluation oncology research progression-free survival (PFS) as a main observation indexes.
Countries
China